Apjohn Ventures is a Kalamazoo, Michigan–based early‑stage venture capital firm focused on investing in life sciences companies in the Midwest, particularly in biotechnology, pharmaceuticals, medical devices and diagnostics, partnering with founders to support scientific innovation and growth. The firm leverages deep sector expertise in pharmaceutical and biotech industries and works closely with scientific advisors and management teams to advance portfolio development and commercialization. Its strategy emphasizes early equity investments alongside strategic guidance and networking to help companies progress toward clinical, regulatory and market milestones. Apjohn has participated in multiple Midwest life science deals and has portfolio companies that achieved exits or significant financings. The fund’s activities reflect a regional commitment to fostering innovation and translating research into commercially viable healthcare solutions.